With the World health Organization declaring new public health emergencies for Clade Ib and IIb mpox, Tonix is positioning TNX-801 as ... TNX-1300 (cocaine esterase), a biologic in Phase 2 development ...

It’s not yet certain which animals are the natural carriers. But, based on the available evidence, it is thought to be ...

Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...

New guidelines for diabetes treatment, mpox research, and healthcare system improvements discussed in comprehensive health ...

Highlights Revenue Milestones and Expands Alternative Protein & Pharmaceutical Partnerships with Dapibus™ & C1 Technology Platforms ...

Vaccines currently available to the global market are Bavarian Nordic’s MVA-BN (JYNNEOS), KM Biologics’ LC16, and Emergent ...

Four cases of the more infectious variant of mpox have been reported in the UK, making it the first cluster of infections that have surfaced outside of Africa.

The World Health Organization says mpox cases in the region of Congo where a new and more infectious variant was first detected appear to be “plateauing,” even as the virus continues to increase in ...

The World Health Organization will convene a meeting of its Emergency Committee next week to determine whether mpox remains a ...

Investigation of the Clade la strain of the virus circulation in Central Africa shows genetic mutations indicative of ...

Kenya is among nine countries in Africa that have been allocated MPOX vaccine doses, following an MPOX surge in the continent ...

Kenya is among the first African countries who have been allocated thousands of doses of the mpox vaccine, with the ...